About Us
Oxford Nanopore is a global technology company at the forefront of DNA and RNA sequencing. Our technology is used by researchers, clinicians and scientists around the world to tackle some of the biggest challenges in healthcare, life sciences and environmental research.
If you are looking for a graduate accounting role that offers meaningful responsibility, structured professional development and exposure to a complex international environment, we'd love to hear from you.
About the Accounting Hub
The Accounting Hub is responsible for delivering high-quality financial accounting, financial control and statutory reporting activities across multiple international entities within the Oxford Nanopore Group.
The team works closely with Group Reporting, Technical Accounting, Tax, Finance Operations, External auditors and Finance Systems teams giving you exposure to a broad range of accounting disciplines from the start of your career.
What you'll be doing:
You'll support activities including:
Over time you'll develop from supporting activities under supervision to taking ownership of designated entities and accounting processes.
What we're looking for:
We're interested in graduates who:
We welcome applications from candidates with or without previous finance experience.
What you'll receive
We encourage early applications, as this role may close sooner than advertised due to high level of interest
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-Hybrid
#LI-ZP1
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
